Close Menu

NEW YORK – With the US now several years into the transition to the International Classification of Diseases, Tenth Revision (ICD-10) medical coding system, payors appear to be tightening their standards for compliance.

According to some lab heads, this has led to an increase in rejection of claims for inappropriate codes, with some labs seeing rejection rates as high as 40 percent.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.